Azure: A sitting duck

At current share price levels the clinical workflow company is a prime takeover target.

Azure Healthcare’s interim result was towards the lower end of guidance from the AGM ($0.8-$1.2 million) with a reported net profit after tax (NPAT) of $0.9 million.


SMS Code Sent…

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

If you didn't receive SMS code please

Log in to access this content

Looks you are already a member. Please enter your password to proceed

Hi {{ user.FirstName }}

Verify your mobile number to unlock a FREE trial

Looks like you've already taken a free trial

Please sign up for full access

Updating information

Please wait ...

Related Articles